16 results
8-K
EX-99.1
PRLD
Prelude Therapeutics Inc
12 Aug 21
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
10:41am
aspects of the Company’s human resources management, including, talent management and strategy, organizational effectiveness, total rewards, culture
10-K
2020 FY
PRLD
Prelude Therapeutics Inc
16 Mar 21
Annual report
8:20am
lines were treated with various concentrations of PRT543 and the number of viable cells was measured after ten days in culture. We observed … concentrations of PRT543 and the number of viable cells was measured after 10 days in culture. We observed that PRT543 demonstrated potent activity
PRE 14A
PRLD
Prelude Therapeutics Inc
18 Apr 23
Preliminary proxy
4:00pm
objective responses to PRT2527, IND studies of PRT3645 and PRT3789, ensuring company-wide compliance and alignment with our budget and
culture objectives
S-1
h6r j9xhy5
4 Sep 20
IPO registration
4:48pm
424B4
akv vohdzsfj
25 Sep 20
Prospectus supplement with pricing info
4:08pm
DRS
p7d3seov tc
23 Jul 20
Draft registration statement
12:00am
DRS
23eqvf6om60bw047
21 Dec 20
Draft registration statement
12:00am
424B4
ouc09m
7 Jan 21
Prospectus supplement with pricing info
4:11pm
DRS/A
e4el5 7ge35
26 Aug 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next